QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
Los Angeles, CA -- (SBWIRE) -- 01/09/2019 -- This report studies the global General Anesthesia Drugs market status and forecast, categorizes the global General Anesthesia Drugs market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.
General anesthetics are drugs that have the ability to bring about a reversible loss of consciousness. Anesthetists administer these drugs to induce or maintain general anaesthesia to facilitate surgery. Some of these drugs are also used in lower dosages for pain management.
General Anesthesia Drugs can be divided into two categories, Intravenous Anesthetics, accounting for 69.62% and Inhalational Anesthetics, accounting for 30.38%. Intravenous Anesthetics widely used drugs are: Propofol, Etomidate, Midazolam, Barbiturates (such as thiopental), and so on. Desflurane, Isoflurane and Sevoflurane are the most widely used Inhalational Anesthetics. Propofol hold the largest market share of General Anesthesia Drugs with 33.83% market share. Sevoflurane market share is over 21.17%, being the second largest market share of General Anesthesia Drugs.
Request Sample Report Copy@ https://www.qyresearch.com/sample-form/form/244779/global-general-anesthesia-drugs-market
Europe is the largest supplier and consumption market of General Anesthesia Drugs, with a production market share of nearly 38% and sales market share nearly 32%. The second place is USA, following Europe with the production market share of 20% and the sales market share over 28%. Asia is another important market of General Anesthesia Drugs, enjoying 24% production market share and 25% sales market share.
The global General Anesthesia Drugs market is valued at 6500 million US$ in 2017 and will reach 8070 million US$ by the end of 2025, growing at a CAGR of 2.7% during 2018-2025.
The major manufacturers covered in this report
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
North America
Europe
China
Japan
Southeast Asia
India
Get Amazing Discount on Market Research Report@ https://www.qyresearch.com/request-discount/form/244779/global-general-anesthesia-drugs-market
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.